Read More Pharma Industry News CytoDyn changed CEOs today. What does Robert Hoffman need to deliver next? CytoDyn has moved former finance chief Robert Hoffman into the CEO role while Jacob Lalezari returns to scientific work, separating corporate execution from research as leronlimab advances deeper into oncology. byPallavi MadhirajuOctober 22, 2026